Role of indivdual susceptibility in risk assessment of pesticides

Occupational and Environmental Medicine

Volumn 56, Issue 7, 1999, Pages 449-453

  Leng, G ^a   Lewalter, J ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BAYER AG   (Germany)

Author keywords

Individual susceptibility; Pesticides; Risk assessment

Indexed keywords

4 NITROPHENOL; ACETYLCHOLINESTERASE; CHOLINESTERASE; CYFLUTHRIN; PARATHION; PARATHION METHYL; PESTICIDE; PHENOL DERIVATIVE; PROPOXUR; INSECTICIDE; NITRILE; PYRETHROID;

ARTICLE; CHEMICAL INDUSTRY; ENZYME ACTIVITY; HUMAN; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; URINALYSIS; ADULT; BLOOD; DISEASE PREDISPOSITION; ENVIRONMENTAL MONITORING; METHODOLOGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; URINE;

ACETYLCHOLINESTERASE; ADULT; CHEMICAL INDUSTRY; CHOLINESTERASES; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL MONITORING; HUMANS; INSECTICIDES; MIDDLE AGED; NITRILES; OCCUPATIONAL EXPOSURE; PARATHION; PESTICIDES; PROPOXUR; PYRETHRINS; RISK ASSESSMENT;

EID: 0032586894     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.56.7.449     Document Type: Article

References (36)

1. 1 Abelson PH. Exaggerated risks of chemicals. J Clin Epidemiol 1995;48:173-8.
2. 2 Lewalter J, Neumann H-G. Biologisches Arbeitsstoff-Toleranzwerte (Biomonitoring),Teil VIII: Bewertung der Hintergrundbelastungen bei beruflich nicht-exponierten Personen. Arbeitsmed Sozialmed Umweltmed 1996;31:418-32.
3. 3 Aitio A. Biological monitoring today and tomorrow. Scand J Work Environ Health 1994;20:46-58.
4. 4 Hoet P, Haufroid V. Biological monitoring: state of the art. Occup Environ Med 1997;54:361-6.
5. 5 International Programme on Chemical Safety. Biomarkers and risk assessment: concept and principles. Geneva: World Health Organisation, 1993. (Environmental Health Criteria 155.)
6. 6 Lewalter J. Monitoring und immunologische Bedeutung von Schadstoffaddukten. Berichte der Österreichischen Gesselschaft Klinische Chemie 1994;17:9-18.
7. 7 Zielhuis RI, Henderson PTh. Definitions of monitoring activities and their relevance for the practice of occupational health. Int Arch Occup Environ Health 1986;57:249-57.
8. 8 European Centre for Ecotoxicology and Toxicology of Chemicals. DNA and protein adducts: evaluation of their use in exposure monitoring and risk assessment. ECETOC, 1989. (Monograph No 13.)
9. 9 Lewalter J. Biologisches Monitoring von Pestiziden. S. Pflanzenschutz- und Schädlingsbekämpfungsmittel-Kolloquium [abstract]. Erlangen, Germany: Angerer J, 1996.
10. 10 Lewalter J, Korallus U. Erythrocyte protein conjugates as a principle of biological monitoring for pesticides. Toxicol Lett 1986;33:153-65.
11. 11 Schulte PA. Review: a conceptual framework for the validation and use of biological markers. Environ Res 1989;48:129-44.
12. 12 Lewalter J, Neumann H-G. Biologische Arbeitsstoff-Toleranzwerte (Biomonitoring), Teil XII: Die Bedeutung der individuellen Empfindlichkeit beim Biomonitoring. Arbeitsmed Sozialmed Umweltmed 1998;33:352-64.
13. 13 Roots J. Genetische Ursachen fūr die Variabilität der Wirkungen und Nebenwirkungen von Arzneimitteln. Der Internist 1982;23:601-9.
14. 14 Wollen BH, Marsh JR, Laird WJD, et al. The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration. Xenobiotica 1992,22:983-91.
15. 15 Lewalter J. Acetylcholinesterase inhibitors. In: Greim H, Lehnert G, eds. Biological exposure values for occupational toxicants and carcinogens. Weinheim, Germany: German Science Foundation, VCH Verlags Gesellschaft, 1995;2:15-24.
16. 16 Aldridge WN. An assessment of the toxicological properties of pyrethroids and their neurotoxicity. Toxicology 1990;21:89-104.
17. 17 Calabrese EJ. Ecogenetics: historical foundation and current status. J Occup Med 1986;28:1096-102.
18. 18 Idle JR, Armstrong M, Boddy A, et al. The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics 1992;2:246-58.
19. 19 Kalow W, Staron N. On the distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Canadian Journal of Biochemistry 1957;35:1305-9.
20. 20 Löhr GW. Über die Bedeutung genetisch bedingter Enzymdefekte für die Pharmakotherapie. In: Löhr GW, Blum KU, Wiedemann OJ, eds. Enzyme und Pharmaka. Grenzach: Editiones Roche, 1970:79-101.
21. 21 Lewalter J, Maniatis H. Parathion (-methyl), paraoxon (-methyl) in plasma. In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: Deutsche Forschungsgemeinschaft, VCH Verlagsgesellschaft, 1999 (in press).
22. 22 Lewalter J, Gries W, Kahre H, et al. o- und p-Nitrophenol in Harn, In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: Deutsche Forschungsgemeinschaft, VCH Verlagsgesellschaft, 1999 (in press).
23. 23 Lewalter J, Wimber M. Propoxur in plasma. In: J Angerer, KH Schaller, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: Deutsche Forschungsgemeinschaft, VCH Verlagsgesellschaft. 1999 (in press).
24. 24 Lewalter J, Schucht Th, Angerer J, et al. Benzene derivatives, suitable for steam distillation. In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: Deutsche Forschungsgemeinschaft, German Science Foundation, VCH Verlagsgesellschaft, 1985;1:31-56.
25. 25 Leng G, Kühn K-H, Idel H. Biological monitoring of pyrethroids in blood and pyrethroid metabolites in urine: applications and limitations. Sci Total Environ 1997;199: 173-81.
26. 26 Lewalter J, Kahre H. Cyfluthrin in plasma. In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany: Deutsche Forschungsgemeinschaft, VCH Verlagsgesellschaft, 1999 (in press).
27. 27 Lewalter J, Domik C, Schaller KH. Acetylcholinesterase and cholinesterase in plasma and erythrozyten. In: Angerer J, Schaller KH, eds. Analyses of hazardous substances in biological materials. Weinheim, Germany; German Science Foundation, VCH Verlagsgesellschaft, 1991;3:45-61.
28. 28 Siedel J, Möllering H, Ziegenhorn J. Sensitive color reagent for the enzymic determination of creatinine. Clin Chem 1984;30:968-9.
29. 29 Schaller KH, Angerer J, Lehnert G. Current status of the external quality assurance programmes of the German Society for Occupational and Environmental Medicine. Toxicol Lett 1995-77:213-7.
30. 30 Schaller KH, Angerer J, Lehnert G. Biologische Arbeitsstoff-Toleranzwerte (Biomonitoring), Teil VII: Qualitätssicherung arbeitsmedizinisch-toxikologischer Analysen - Erfordernisse für die ärztliche Beurteilung von Ergebnissen des Biomonitoring. Arbeitsmed Sozialmed Umweltmed 1996;31:317-23.
31. 31 Technische Regel für gefährliche Arbeitsstoffe 410 (TRgA 410). Statistische Qualitätssicherung. Bundesarbeitsblatt. 1979;6:88-92.
32. 32 Riegner K. Modifikation der Methode 00323 (RA-251/93) zur Bestimmung von Parathion-ethyl in Luft. BAYER AG, unveröffentlichter Bericht, RA-174/94, Methode 00323-M001, 1994. Leverkusen, Germany: Bayer, 1994
33. 33 Leng G, Leng A, Kühn K-H, et al. Human dose-excretion studies with the pyrethroid insecticide cyfluthrin: urinary metabolite profile following inhalation. Xenobiotica 1997;27:1272-83.
34. 34 Kühn K-H, Leng G, Bucholski KA, et al. Determination of pyrethroid metabolites in human urine by capillary gas chromatography-mass spectrometry. Chromatographia 1996;43:285-92.
35. 35 Leng G, Kühn K-H, Kühn I H. Biological monitoring of pyrethroid metabolites in urine of pest control operators. Toxicol Lett 1996;88:215-20.
36. 36 Kolmodin-Hedman B, Akerblom M, Flato S, et al. Symptoms in forestry workers handling conifer plants treated with permethrin. Bull Environ Contam Toxicol 1995;55:487-93.